Federico Grossi - 05 Jan 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
_/s/ David Watson, attorney-in-fact for Federico Grossi
Issuer symbol
APLS
Transactions as of
05 Jan 2023
Transactions value $
-$121,975
Form type
4
Filing time
09 Jan 2023, 18:02:36 UTC
Previous filing
02 Dec 2022
Next filing
07 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$122K -2.5K -2.57% $48.79 94.9K 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10b5-1 trading plan.